News & Events (2)

June 22, 2022

Assessing Drug-induced Gut Toxicity In Vitro

This webinar addresses the challenges of assessing drug-induced gut toxicity in vitro and introduces the Altis RepliGut Planar Model

May 12, 2022

Altis named one of the top 20 most innovative organ-on-a-chip companies in the world.

Top 20 most innovative organ-on-a-chip companies

February 3, 2022

Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute

Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of human intestinal stem...

January 27, 2022

Altis Biosystems Appoints Jimmy Smedley, Ph.D. Chief Operating Officer

Altis Biosystems appoints Jimmy Smedley, Ph.D., as Chief Operating Officer to lead operations and market strategies for products and services.

Immuno-Oncology Summit

October 4-6, 2021

Westin Copley Place & Virtual Event